期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

新型肝素结合细胞因子midkine的心血管作用 被引量：3

Effect of midkine,a newly heparin-binding cytokine,on cardiovascular functions
下载PDF
导出
摘要 Midkine (MK),a newly discovered heparin-binding growth factor,promotes growth,survival,and migration in various cells. Meanwhile,MK stimulates statistically significant forms in new arterioles and capillaries,causes vascular remodeling,prevents ischemia myocardial cells from injury via inhibiting apoptosis. MK also regulates the level of blood-fat. In general,MK plays key roles in cardiovascular diseases. Midkine （MK）, a newly discovered heparin -binding growth factor, promotes growth, survival, and migration in various cells. Meanwhile, MK stimulates statistically significant forms in new arterioles and capillaries, causes vascular remodeling, prevents ischemia myocardial cells from injury via inhibiting apoptosis. MK also regulates the level of blood - fat. In general, MK plays key roles in cardiovascular diseases.
作者 刘笑然 叶琳 马兰 唐朝枢
机构地区 海南医学院病理生理教研室 海南现代女子医院神经内科 北京大学第一医院心血管研究所
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2009年第11期2221-2224,共4页 Chinese Journal of Pathophysiology
基金 海南省自然科学基金资助项目(No.309064)
关键词 MIDKINE 血管生成 心血管系统 细胞凋亡 Midkine Angiogenesis Cardiovascular system Apoptosis
分类号 R54 [医药卫生—心血管疾病]
  • 相关文献

参考文献17

  • 1Uehara K, Matsubara S, Kadomatsu K, et al. Genomic structure of human midkine ( MK), a retinoic acid - responsive growth/differentiation factor [ J ]. Biochem ( Tokyo), 1992,111(5) :563 -567.
  • 2Matsuda Y, Talukder AH, Ishihara M, et al. Limited proteolysis by chymotrypsin of midkine and inhibition by heparin binding[J].Biochem Biophys Res Commun, 1996, 228(1) :176 - 181.
  • 3Kadomatsu K, Tomomura M, Muramatsu T, et al. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid - gestation period of mouse embryogenesis[ J]. Biochem Biophys Res Commun, 1988,151 (3): 1312 -1318.
  • 4Muramatsu H, Shirahama H, Yonezawa S, et al. Mid- kine, a retinoic acid - inducible growth/differentiation factor: immunochemical evidence for the function and distribution [J]. Dev Biol, 1993,159 (2) : 392 - 402.
  • 5Sato W, Yuzawa Y, Kadomatsu K, et al. Midkine expression in the course of nephrogenesis and its role in ischaemic reperfusion injury [ J ]. Nephrol Dial Transplant, 2002,17 ( Suppl 9):52 - 54.
  • 6Zhang YW, Denham J, Thies RS, et al. Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors [ J ]. Stem Cells Dev, 2006,15 (6) :943 -952.
  • 7Wada M, Kamata M, Aizu Y, et al. Alteration of midkine expression in the ischemic brain of humans [ J ]. Neurol Sci, 2002,200( 1 -2) :67 -73.
  • 8张明,高献书,何志嵩,刘朝兴.膀胱移行细胞癌中MK表达与其临床病理特征及预后的关系[J].中国病理生理杂志,2008,24(12):2370-2373. 被引量：5
  • 9Shimada H, Nabeya Y, Tagawa M, et al. Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma[ J]. Cancer Sci, 2003,94 (7) :628 -632.
  • 10Sumi Y, Muramatsu H, Takei Y, et ah Midkine, a hepatin - binding growth factor, promotes growth and glycosaminoglycan synthesis of endothelial cells through its action on smooth muscle cells in an artificial blood vessel model[J]. Cell Sci, 2002,115(Pt 13) :2659 -2667.

二级参考文献12

  • 1李昕,朱步东.中期因子与肿瘤[J].国外医学（肿瘤学分册）,2005,32(10):745-748. 被引量：1
  • 2Adachi Y, Matsubara S, Pedraza C, et al. Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1) [J]. Oncogene,1996,13(10) :2197 -2203.
  • 3Garver RI, Chan CS, Milner PG. Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues[J]. Am J Respir Cell Mol Biol, 1993,9(5) :463 --466.
  • 4Garver RI, Radford DM, Donis - Keller H, et al. Midkine and pleiotrophin expression in normal and malignant breast tissue[J]. Cancer, 1994,74(5) :1584- 1590.
  • 5Kaname T, Kadomatsu K, Aridome K, et al. The expression of truncated MK in human tumors [ J ]. Biochem Biophys Res Commun, 1996,219 ( 1 ) :256 - 260.
  • 6Miyauchi M, Shimada H, Kadomatsu K, et al. Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy [J]. J Cancer Res, 1999,90(4) :469 -475.
  • 7Ye C, Qi M, Fan QW, et al. Expression of midkine in the early stage of carcinogenesis in human colorectal cancer[ J]. Br J Cancer, 1999,79( 1 ) : 179 - 184.
  • 8O'Brien T, Cranston D, Fuggle S, et al. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers[J]. Cancer Res, 1996,56( 11 ) :2515 - 2518.
  • 9Muramaki M, Miyake H, Hara I, et al. Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increase their sensitivity to antiangiogenic therapy [ J ]. Clin Cancer Res, 2003, 9 (14) :5152 -5160.
  • 10Ikematsu S, Yano A, Aridome K, et al. Serum midkine levels are increased in patients with various types of carcinomas[J]. Br J Cancer, 2000,83(6) :701 -706.

共引文献4

同被引文献23

引证文献3

二级引证文献9

中国病理生理杂志
2009年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部